← SynDRA
BISANTRENE
SynDRA canonical compound SYN0001336 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | TOP2A | TOP2B |
|---|
| Mechanism of action | topoisomerase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ACHE
- ADORA3
- ADRA1A
- ALKBH5
- CHRM1
- CHRM2
- DRD1
- DRD3
- HTR1A
- IFNG
- OPRM1
- SLC6A2
- SLC6A3
- SLC6A4
Drug classes
- Antibiotics, Antineoplastic
- Antineoplastic Agents
Cross-references
Synonyms
- bisantrene dihydrochloride
- bisantrene hydrochloride
- Bisantreno
- Bisantrenum
- NSC-337766
- CHEBI:88337
- RefChem:120348
- Bisantrene [INN]
- Bisantrenum [INN-Latin]
- Bisantreno [INN-Spanish]
- 9,10-Anthracendicarbaldehyde bis(2-imidazolin-2-ylhydrazon)
- BRN 0966309
- Bisantrene?
- UNII-39C34M111K
- CL216942
- BISANTRENE [MI]
- BISANTRENE [WHO-DD]
- orb1303248
- SCHEMBL8906393
- SCHEMBL29398210
- EX-A2382
- BDBM50060768
- CCG-35603
- MFCD01743164
- AKOS016014320
- CS-6132
- AC-35847
- AS-75775
- HY-100875
- T4047
- D95045
- BRD-K64298650-300-01-5
- N-[(E)-[10-[(E)-(4,5-dihydro-1H-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1H-imidazol-2-amine
- Orange crush
- Bisantrene Hydrochloride
- CL-216942
- MS-28714
- Bisantrene HCl
Look up BISANTRENE in the interactive SynDRA portal →